78.22

3.69% 2.78

Monopar Therapeutics Inc (MNPR)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$75.44

Offen:

$75.13

24-Stunden-Volumen:

164.80K

Relative Volume:

1.39

Marktkapitalisierung:

$522.71M

Einnahmen:

Nettoeinkommen (Verlust:

$-7.12M

KGV:

-34.01

EPS:

-2.3

Netto-Cashflow:

$-6.82M

1W Leistung:

+1.34%

1M Leistung:

-5.85%

6M Leistung:

+126.69%

1J Leistung:

+242.17%

1-Tages-Spanne:

$74.84

$79.31

1-Wochen-Bereich:

$74.50

$85.01

52-Wochen-Spanne:

$21.00

$105.00

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Firmenname

Monopar Therapeutics Inc

Sektor

Healthcare (1124)

Branche

Biotechnology (627)

Telefon

(847) 388-0349

Adresse

1000 SKOKIE BLVD SUITE 350, WILMETTE

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

MNPR's Discussions on Twitter

Vergleichen Sie MNPR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MNPR Monopar Therapeutics Inc	78.22	504.13M	0	-7.12M	-6.82M	-2.30
VRTX Vertex Pharmaceuticals Inc	444.64	110.88B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	726.21	72.79B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	890.11	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	404.46	54.85B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	189.85	41.41B	447.02M	-1.18B	-906.14M	-6.1812

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-14	Herabstufung	Raymond James	Strong Buy → Outperform
2025-11-10	Eingeleitet	Leerink Partners	Outperform
2025-10-13	Eingeleitet	Barclays	Overweight
2025-09-09	Eingeleitet	BTIG Research	Buy
2025-09-03	Eingeleitet	Oppenheimer	Outperform
2025-09-03	Eingeleitet	Raymond James	Strong Buy
2025-08-26	Fortgesetzt	H.C. Wainwright	Buy
2025-07-07	Eingeleitet	Cantor Fitzgerald	Overweight
2025-06-23	Eingeleitet	Chardan Capital Markets	Buy
2025-03-19	Fortgesetzt	Piper Sandler	Overweight
2025-01-10	Eingeleitet	Piper Sandler	Overweight
2024-10-11	Eingeleitet	Rodman & Renshaw	Buy
2021-01-28	Eingeleitet	ROTH Capital	Buy

Alle ansehen

Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten

Dec 08, 2025

Aug Catalysts: How interest rate cuts could boost Monopar Therapeutics Inc stockGap Up & High Accuracy Trade Alerts - BỘ NỘI VỤ

Dec 08, 2025

Dec 06, 2025

Monopar Therapeutics (NASDAQ:MNPR) Shares Up 6.3%Should You Buy? - MarketBeat

Dec 06, 2025

Monopar Therapeutics (NASDAQ:MNPR) Downgraded to Sell Rating by Wall Street Zen - MarketBeat

Dec 06, 2025

Dec 04, 2025

Will Monopar Therapeutics Inc. stock benefit from commodity prices2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser

Dec 04, 2025

Will Monopar Therapeutics Inc. (1IY0) stock rise with strong economyShare Buyback & Free Weekly Watchlist of Top Performers - Newser

Dec 04, 2025

How Monopar Therapeutics Inc. (1IY0) stock behaves in tightening cyclesJuly 2025 Setups & Consistent Growth Equity Picks - Newser

Dec 04, 2025

Is Monopar Therapeutics Inc. (1IY0) stock a safe buy pre earningsJuly 2025 Gainers & Verified Technical Signals - Newser

Dec 04, 2025

How (MNPR) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Dec 04, 2025

Dec 03, 2025

Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat

Dec 03, 2025

How Monopar Therapeutics Inc. (1IY0) stock correlates with oil markets2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser

Dec 03, 2025

Can Monopar Therapeutics Inc. (1IY0) stock stage a strong rebound this quarterRecession Risk & Risk Controlled Stock Alerts - Newser

Dec 03, 2025

Is Monopar Therapeutics Inc. (1IY0) stock worth buying before Fed actionMarket Activity Report & High Accuracy Investment Signals - Newser

Dec 03, 2025

Nov 27, 2025

Is Monopar Therapeutics Inc. stock a safe investment in uncertain markets2025 Support & Resistance & Entry Point Strategy Guides - moha.gov.vn

Nov 27, 2025

Monopar Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Free Rapid Portfolio Appreciation - earlytimes.in

Nov 27, 2025

Monopar Therapeutics (NASDAQ:MNPR) Shares Down 4%Time to Sell? - MarketBeat

Nov 27, 2025

What dividend safety score for Monopar Therapeutics Inc. stockNew Guidance & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Is Monopar Therapeutics Inc. stock a safe haven asset2025 Fundamental Recap & Weekly Breakout Watchlists - BỘ NỘI VỤ

Nov 26, 2025

Monopar Therapeutics (NASDAQ:MNPR) Shares Gap UpHere's What Happened - MarketBeat

Nov 26, 2025

Nov 24, 2025

Monopar Therapeutics Unveils Promising Phase 2 Study Results - MSN

Nov 24, 2025

Nov 23, 2025

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments - ADVFN

Nov 23, 2025

Trading Systems Reacting to (MNPR) Volatility - news.stocktradersdaily.com

Nov 23, 2025

Nov 22, 2025